Company profile for Drug Farm

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Here at Drug Farm we are developing innovative treatments targeting the innate immunity for hepatitis B, cancer and autoimmune diseases. Drug Farm's unique InVivo platform combines breakthrough technologies in genetics and AI. IDInVivo technology allows the direct assessment of gene targets in living animals with intact immune systems. Using ID InVivo platform, Drug Farm has identified novel innate immunity pathways and targ...
Here at Drug Farm we are developing innovative treatments targeting the innate immunity for hepatitis B, cancer and autoimmune diseases. Drug Farm's unique InVivo platform combines breakthrough technologies in genetics and AI. IDInVivo technology allows the direct assessment of gene targets in living animals with intact immune systems. Using ID InVivo platform, Drug Farm has identified novel innate immunity pathways and targets, and is now rapidly advancing multiple first-in-class drug candidates into clinical development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Floor 7, 43 Handan Road, Hongkou District, Shanghai, 200437
Telephone
Telephone
+86-021-61428556
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-09-23/drug-farm-announces-agreement-with-cincinnati-children-s-hospital-medical-center-to-explore-alpk1-in

PHARMAWEB
23 Sep 2025

https://www.pharmiweb.com/press-release/2025-09-09/drug-farm-announces-publication-in-nature-communications-describing-the-discovery-and-preclinical-ch

PHARMAWEB
09 Sep 2025

https://www.businesswire.com/news/home/20250804338505/en/Drug-Farm-Announces-First-Patients-Dosed-in-Phase-1b-Clinical-Trial-Evaluating-ALPK1-Inhibitor-DF-003-in-ROSAH-Syndrome

BUSINESSWIRE
04 Aug 2025

https://www.businesswire.com/news/home/20250529149642/en/Drug-Farm-Reports-Data-on-Safety-and-Pharmacokinetics-from-Phase-1-First-in-Human-Trial-of-DF-003-in-Healthy-Volunteers

BUSINESSWIRE
29 May 2025

https://www.businesswire.com/news/home/20250527594909/en/Drug-Farm-and-Xiamen-Amoytop-Biotech-Co.-Ltd.-Enter-into-Option-Agreement-for-First-In-Class-Innate-Immunity-Agonist-DF-006-to-Treat-Hepatitis-B-and-Hepatocellular-Cancer

BUSINESSWIRE
27 May 2025

https://www.businesswire.com/news/home/20240517668307/en

BUSINESSWIRE
17 May 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty